valsartan has been researched along with Bilirubinemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aoki, S; Ito, K; Kosaka, K; Kume, T; Sekine, S; Susukida, T; Watanabe, T | 1 |
Adachi, Y; Hirouchi, M; Hu, Z; Maeda, K; Sugiyama, Y; Yamashiro, W | 1 |
2 other study(ies) available for valsartan and Bilirubinemia
Article | Year |
---|---|
Key determinants of the circulatory exposure of organic anions: differences in hepatic uptake between multidrug resistance-associated protein 2 (Mrp2)-deficient rats and wild-type rats.
Topics: Animals; ATP-Binding Cassette Transporters; Estradiol; Glucuronates; Hyperbilirubinemia; Liver; Male; Piperidines; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Valsartan | 2015 |
Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans.
Topics: Adenosine Triphosphate; Angiotensin II Type 1 Receptor Blockers; Animals; Bile; Cell Line; Cell Membrane; Disease Models, Animal; Estrone; Hepatocytes; Humans; Hyperbilirubinemia; Liver-Specific Organic Anion Transporter 1; Male; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Rats; Rats, Sprague-Dawley; Sincalide; Solute Carrier Organic Anion Transporter Family Member 1B3; Tetrazoles; Transfection; Valine; Valsartan | 2006 |